These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39003103)

  • 1. Validation of the newly proposed Brighton Collaboration case definition for vaccine-induced immune thrombocytopenia and thrombosis.
    Huang WT; Law B; Tran H; Schönborn L; Huang WI; Buttery J; Chen VMY; Greinacher A; Pavord S
    Vaccine; 2024 Nov; 42(25):126131. PubMed ID: 39003103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of VITT.
    Pai M
    Semin Hematol; 2022 Apr; 59(2):72-75. PubMed ID: 35512903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
    Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Aspects of VITT.
    Schönborn L; Greinacher A
    Semin Hematol; 2022 Apr; 59(2):108-114. PubMed ID: 35512899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.
    Greinacher A; Selleng K; Palankar R; Wesche J; Handtke S; Wolff M; Aurich K; Lalk M; Methling K; Völker U; Hentschker C; Michalik S; Steil L; Reder A; Schönborn L; Beer M; Franzke K; Büttner A; Fehse B; Stavrou EX; Rangaswamy C; Mailer RK; Englert H; Frye M; Thiele T; Kochanek S; Krutzke L; Siegerist F; Endlich N; Warkentin TE; Renné T
    Blood; 2021 Dec; 138(22):2256-2268. PubMed ID: 34587242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential mechanisms of vaccine-induced thrombosis.
    Marietta M; Coluccio V; Luppi M
    Eur J Intern Med; 2022 Nov; 105():1-7. PubMed ID: 35953336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    McGonagle D; De Marco G; Bridgewood C
    J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VITT and Second Doses of Covid-19 Vaccine.
    Lacy J; Pavord S; Brown KE
    N Engl J Med; 2022 Jan; 386(1):95. PubMed ID: 34936738
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada.
    Procter TD; Ogasawara H; Spruin S; Wijayasri S; Abraham N; Blaser C; Hutchings K; Shaw A; Ogunnaike-Cooke S
    Vaccine; 2023 Nov; 41(46):6802-6809. PubMed ID: 37806804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
    Greinacher A; Selleng K; Mayerle J; Palankar R; Wesche J; Reiche S; Aebischer A; Warkentin TE; Muenchhoff M; Hellmuth JC; Keppler OT; Duerschmied D; Lother A; Rieg S; Gawaz MP; Mueller KAL; Scheer CS; Napp M; Hahnenkamp K; Lucchese G; Vogelgesang A; Flöel A; Lovreglio P; Stufano A; Marschalek R; Thiele T;
    Blood; 2021 Oct; 138(14):1269-1277. PubMed ID: 34280256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine.
    van der Neut Kolfschoten M; Inganäs H; Perez-Peinado C; Calado da Silva Freire J; Melchers JM; van Dijk N; Przeradzka M; Kourkouta E; van Manen D; Vellinga J; Custers J; Bos R
    J Thromb Haemost; 2024 Apr; 22(4):1046-1055. PubMed ID: 38159648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications.
    Zidan A; Noureldin A; Kumar SA; Elsebaie A; Othman M
    Semin Thromb Hemost; 2023 Feb; 49(1):9-14. PubMed ID: 36603593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil.
    Mouta Nunes de Oliveira P; Mendes-de-Almeida DP; Bertollo Gomes Porto V; Crespo Cordeiro C; Vitiello Teixeira G; Saraiva Pedro R; Roberto Gomes Takey P; Kegele Lignani L; Reis Xavier J; Cardoso Doria da Gama V; Amorim Filho L; Emoingt Furtado B; Santa Maria A; Dahrug Barros T; Neves Waite Freitas L; Dos Santos Pereira T; Lima Abreu D; Bernardes Ramos M; Gabe C; Arnold D; William Smith J; Nazy I; Lourdes de Sousa Maia M;
    Vaccine; 2022 Aug; 40(33):4788-4795. PubMed ID: 35779962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Greinacher A; Schönborn L; Siegerist F; Steil L; Palankar R; Handtke S; Reder A; Thiele T; Aurich K; Methling K; Lalk M; Völker U; Endlich N
    Semin Hematol; 2022 Apr; 59(2):97-107. PubMed ID: 35512907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.
    Rodriguez EVC; Bouazza FZ; Dauby N; Mullier F; d'Otreppe S; Jissendi Tchofo P; Bartiaux M; Sirjacques C; Roman A; Hermans C; Cliquennois M
    Infection; 2022 Apr; 50(2):531-536. PubMed ID: 34626338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uncommon thrombotic complications after SARS-CoV-2 vaccination].
    Musil D
    Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    Pavord S; Scully M; Hunt BJ; Lester W; Bagot C; Craven B; Rampotas A; Ambler G; Makris M
    N Engl J Med; 2021 Oct; 385(18):1680-1689. PubMed ID: 34379914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia.
    Chen VM; Curnow JL; Tran HA; Choi PY
    Med J Aust; 2021 Sep; 215(6):245-249.e1. PubMed ID: 34490632
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke.
    Kenda J; Lovrič D; Škerget M; Milivojević N
    J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106072. PubMed ID: 34461442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE).
    Major A; Carll T; Chan CW; Christenson C; Aldarweesh F; Wool GD; Cohen KS
    J Clin Apher; 2022 Feb; 37(1):117-121. PubMed ID: 34672380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.